Paper

Upadacitinib Is Associated With the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis: A Real-World Administrative Claims Study

Clinical Gastroenterology and Hepatology · 2026 · Marianne Hupé, Dhruv Ahuja, Kuan-Hung Yeh et al.